EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AI-Enhanced Medication Management for Acute Kidney Injury in Critical Care Settings

Dr Naveen Angadi, Dr Hiten Kareliya, Dr Udgeeth Thaker, Bhupal Arya, Dr. A. Ganeshbala, Rani Medidha

KIDNEYS · 26.01.2026 · 15 (1) · 212-220

DOI: 10.65327/kidneys.v15i1.611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift KIDNEYS, online erschienen am 26.01.2026. Verfasst von Dr Naveen Angadi und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute kidney injury (AKI) is a frequent complication in critically ill patients and is often exacerbated by inappropriate medication dosing and exposure to nephrotoxic drugs. Rapid renal function changes and high medication burden in the intensive care unit (ICU) make renal-safe prescribing challenging. Artificial intelligence (AI)-assisted clinical decision support systems may aid medication optimisation during AKI.

Objective

To evaluate the association between AI-assisted medication review and renal dose appropriateness in critically ill patients with AKI, and to assess AKI progression and renal recovery during ICU admission.

Methods

A single-centre observational study was conducted in an adult ICU. Adult patients diagnosed with AKI using the Kidney Disease: Improving Global Outcomes (KDIGO) criteria and receiving at least one medication were included. Renal function was monitored using serum creatinine and urine output. Medications were assessed for renal dose appropriateness. An AI-assisted decision support tool provided dosing and nephrotoxicity recommendations without autonomous prescribing during routine clinical care settings.

Results

Patients had a mean age of 63 ± 12 years and received multiple medications during AKI. Renal dose appropriateness improved from 66% to 85% following AI-assisted review. Renal function improved in 44% of patients, while 23% experienced worsening AKI.

Conclusions

AI-assisted medication review was associated with improved renal-safe prescribing in critically ill patients with AKI, supporting its role as a clinician-centred adjunct in intensive care.

Zitieren

APA

Angadi, D. N., Kareliya, D. H., Thaker, D. U., Arya, B., Ganeshbala, D. A., & Medidha, R. (2026). AI-Enhanced Medication Management for Acute Kidney Injury in Critical Care Settings. KIDNEYS, 15(1), 212-220. https://doi.org/10.65327/kidneys.v15i1.611

Vancouver

Angadi DN, Kareliya DH, Thaker DU, Arya B, Ganeshbala DA, Medidha R. AI-Enhanced Medication Management for Acute Kidney Injury in Critical Care Settings. KIDNEYS. 2026;15(1):212-220. doi:10.65327/kidneys.v15i1.611

BibTeX
@article{Angadi2026,
  author = {Angadi, Dr Naveen and Kareliya, Dr Hiten and Thaker, Dr Udgeeth and Arya, Bhupal and Ganeshbala, Dr. A. and Medidha, Rani},
  title = {AI-Enhanced Medication Management for Acute Kidney Injury in Critical Care Settings},
  journal = {KIDNEYS},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {212--220},
  doi = {10.65327/kidneys.v15i1.611}
}
Kostenlos starten →